The Top Growth Stocks, Ranked by Seeking Alpha Analyst Ratings
Arcellx (NASDAQ:ACLX) Is In A Strong Position To Grow Its Business
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a ne
Arcellx(ACLX.US) Officer Sells US$1.11 Million in Common Stock
$Arcellx(ACLX.US)$ Officer Heery Christopher sold 20,000 shares of common stock on Jul 1, 2024 at an average price of $55.3881 for a total value of $1.11 million.Source: Announcement What is statement
Stifel Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $83
Stifel analyst Benjamin Burnett maintains $Arcellx(ACLX.US)$ with a buy rating, and maintains the target price at $83.According to TipRanks data, the analyst has a success rate of 34.5% and a total av
Insider Sale: CFO Michelle Gilson Sells 12,877 Shares of Arcellx Inc (ACLX)
Arcellx(ACLX.US) Director Sells US$542.66K in Common Stock
$Arcellx(ACLX.US)$ Director Patel Kavita sold 10,000 shares of common stock on Jun 27, 2024 at an average price of $54.2656 for a total value of $542.66K.Source: Announcement What is statement of chan
Arcellx(ACLX.US) Officer Sells US$691.52K in Common Stock
$Arcellx(ACLX.US)$ Officer Gilson Michelle sold 12,877 shares of common stock on Jun 26, 2024 at an average price of $53.7019 for a total value of $691.52K.Source: Announcement What is statement of ch
Form 144 | Arcellx(ACLX.US) Officer Proposes to Sell 692.65K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 26, $Arcellx(ACLX.US)$ Officer MICHELLE GILSON intends to sell 12,877 shares of its common stock on Jun 26, with a total market value of approximately $692.65K. MICHELLE
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
BofA Securities Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $84
BofA Securities analyst Jason Gerberry maintains $Arcellx(ACLX.US)$ with a buy rating, and maintains the target price at $84.According to TipRanks data, the analyst has a success rate of 44.8% and a t
We Think Arcellx (NASDAQ:ACLX) Can Easily Afford To Drive Business Growth
Truist Securities Maintains Buy on Arcellx, Maintains $87 Price Target
Truist Securities analyst Asthika Goonewardene maintains Arcellx with a Buy and maintains $87 price target.
Truist Financial Maintains Arcellx(ACLX.US) With Buy Rating
Truist Financial analyst Asthika Goonewardene maintains $Arcellx(ACLX.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 31.7% and a total average return of -4.5% ove
Arcellx(ACLX.US) Officer Sells US$1.1 Million in Common Stock
$Arcellx(ACLX.US)$ Officer Heery Christopher sold 20,000 shares of common stock on Jun 12, 2024 at an average price of $55.1334 for a total value of $1.1 million.Source: Announcement What is statement
Arcellx Insider Sold Shares Worth $1,102,668, According to a Recent SEC Filing
Christopher Heery, Chief Medical Officer, on June 12, 2024, sold 20,000 shares in Arcellx (ACLX) for $1,102,668. Following the Form 4 filing with the SEC, Heery has control over a total of 9,278 share
Goldman Cuts 2seventy Bio to Neutral, Cites Competition Concerns
Growth Investors: Industry Analysts Just Upgraded Their Arcellx, Inc. (NASDAQ:ACLX) Revenue Forecasts By 14%
Arcellx, Inc. (NASDAQ:ACLX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The revenue forecast for this year has e
Expert Ratings For Arcellx
Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Arcellx (NASDAQ:ACLX) in the last three months.The table below provides a concise overview of r
Arcellx Initiated at Overweight by Piper Sandler
Arcellx Initiated at Overweight by Piper Sandler
Express News | Piper Sandler Initiates Coverage On Arcellx With Overweight Rating, Announces Price Target of $70